Inventor · disambiguated record
Shuaixiang Zhou
Also filed as: ZHOU SHUAIXIANG
3 granted patents·15 pending applications·2 citations·filing 2019–2023
52Inventor score
Top patents by PatentIndex Score
18 records- 0175US12098195B2Anti-IL-23p19 antibody and use thereof in treating diseasesINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted Sep 24, 2024·1 cites·27 claims
- 0270US12269855B2Interleukin-2 and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted Apr 8, 2025·1 cites·12 claims
- 0358US2024391973A1Interleukin-2 mutant and fusion protein thereofFORTVITA BIOLOGICS SINGAPORE PTE LTD·Filed 2022·Application pending·0 cites
- 0457US2025002570A1Anti-vegf a and vegf c bispecific antibodies and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0557US2025073347A1Antibody-drug conjugate targeting claudin18.2FORTVITA BIOLOGICS SINGAPORE PTE LTD·Filed 2022·Application pending·0 cites
- 0655US2024343799A1ANTI-CD79BxCD3 BISPECIFIC ANTIBODY AND USE THEREOFINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 0754US2023391854A1Monoclonal antibody for coronavirus spike protein, and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0854US2025381269A1Bispecific antibody binding egfr and b7-h3FORTVITA BIOLOGICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0952US2023235047A1Anti-claudin18.2 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1050US2024101677A1Single-domain antibody against cd16a and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1150US2023357389A1Anti-claudin18.2 and cd3 bispecific antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1248US2023374132A1Anti-cd3 antibody and uses thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1346US11807663B2Fully humanized anti-B cell maturation antigen (BCMA) single-chain antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted Nov 7, 2023·0 cites·19 claims
- 1446US2024228579A1Fc mutant with altered binding to fc receptorINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1546US2023174604A1Interleukin-2 mutant and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1645US2024034795A1Protein containing heterodimer antibody fc, and preparation method thereforINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1744US2024043487A1Interleukin-21 mutant and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1843US2023145766A1Interleukin-2 mutant and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuaixiang Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →